Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000440758 | SCV000527726 | benign | not specified | 2016-05-17 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000440758 | SCV000705139 | benign | not specified | 2017-01-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001081689 | SCV001003261 | benign | Developmental and epileptic encephalopathy, 36 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000862718 | SCV001142983 | benign | not provided | 2019-05-23 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001081689 | SCV002524941 | benign | Developmental and epileptic encephalopathy, 36 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001081689 | SCV002807142 | benign | Developmental and epileptic encephalopathy, 36 | 2021-08-16 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000862718 | SCV005277917 | benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV000862718 | SCV001928387 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000862718 | SCV001972038 | likely benign | not provided | no assertion criteria provided | clinical testing |